Evidence map›Paper›PMID 35314870›Full record

ArticleDiabetologia2022

Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts.

Paz L D Ruiz, Lei Chen, Jedidiah I Morton, Agus Salim, Bendix Carstensen, Edward W Gregg, Meda E Pavkov, Manel Mata-Cases, Didac Mauricio, Gregory A Nichols and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Life stage transitions for people with type 1 diabetes.The lancet. Diabetes & endocrinology · 2025
    Review
  8. Observational
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 6 countries.

Paz L D RuizDepartment of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Lei ChenDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.ORCID 0000-0002-6581-0544
Jedidiah I MortonDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Agus SalimDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Bendix CarstensenClinical Epidemiology, Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Edward W GreggDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Meda E PavkovDivision of Diabetes Translation, Centers for Diseases Control and Prevention, Atlanta, GA, USA.
Manel Mata-CasesCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.
Didac MauricioCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain.
Gregory A NicholsScience Programs Department, Kaiser Permanente Center for Health Research, Portland, OR, USA.
Santa PildavaResearch and Health Statistics Department, Centre for Disease Prevention and Control, Riga, Latvia.
Stephanie H ReadUsher Institute, University of Edinburgh, Edinburgh, UK.
Sarah H WildUsher Institute, University of Edinburgh, Edinburgh, UK.
Jonathan E ShawDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Dianna J MaglianoDiabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. Dianna.Magliano@monash.edu.
Baker Heart and Diabetes Institute · AUInstituto de Salud Carlos III · ESUniversity of Edinburgh · GBCenters for Disease Control and Prevention · USImperial College London · GBKaiser Permanente Center for Health Research · USOslo University Hospital · NOSteno Diabetes Centers · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisMortality has declined in people with type 1 diabetes in recent decades. We examined how the pattern of decline differs by country, age and sex, and how mortality trends in type 1 diabetes relate to trends in general population mortality.

methodsWe assembled aggregate data on all-cause mortality during the period 2000-2016 in people with type 1 diabetes aged 0-79 years from Australia, Denmark, Latvia, Scotland, Spain (Catalonia) and the USA (Kaiser Permanente Northwest). Data were obtained from administrative sources, health insurance records and registries. All-cause mortality rates in people with type 1 diabetes, and standardised mortality ratios (SMRs) comparing type 1 diabetes with the non-diabetic population, were modelled using Poisson regression, with age and calendar time as quantitative variables, describing the effects using restricted cubic splines with six knots for age and calendar time. Mortality rates were standardised to the age distribution of the aggregate population with type 1 diabetes.

resultsAll six data sources showed a decline in age- and sex-standardised all-cause mortality rates in people with type 1 diabetes from 2000 to 2016 (or a subset thereof), with annual changes in mortality rates ranging from -2.1% (95% CI -2.8%, -1.3%) to -5.8% (95% CI -6.5%, -5.1%). All-cause mortality was higher for male individuals and for older individuals, but the rate of decline in mortality was generally unaffected by sex or age. SMR was higher in female individuals than male individuals, and appeared to peak at ages 40-70 years. SMR declined over time in Denmark, Scotland and Spain, while remaining stable in the other three data sources. CONCLUSIONS/

interpretationAll-cause mortality in people with type 1 diabetes has declined in recent years in most included populations, but improvements in mortality relative to the non-diabetic population are less consistent.

Indexed as

Diabetes Mellitus, Type 1Age DistributionAustraliaFemaleHumansMaleMortalityRegistriesSpainConsortiumMortalityNon-communicable diseasePopulation healthTrendsType 1 diabetes

Identifiers

PMID35314870
PMCPMC9076725
OpenAlexW4220668656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.